NCT01276808

Brief Summary

Rationale: Magnetic navigation in complex lesions/vessels may result in reduced contrast and irradiation for patients undergoing percutaneous coronary intervention. The investigators aim to compare the use of the 2 techniques. Objective: To compare the use of contrast and irradiation used in magnetically navigated PCI (MPCI) with conventional guidewire PCI (CPCI) in patients with complex anatomy (as defined by a clinical prediction rule). Study design: Prospective randomised controlled, single-blind trial Study population: Healthy human volunteers aged 18 to 80 years of age Intervention (if applicable): One group has the placement of the angioplasty wire with magnetic navigation and the other has the angioplasty wire placed by conventional technique. All other interventions will be performed as per routine practice. Main study parameters/endpoints: Primary endpoint The primary endpoint is the amount of contrast used. Secondary endpoints

  1. 1.Contrast needed to cross a lesion
  2. 2.procedural time
  3. 3.radiation exposure
  4. 4.Clinical complications at 1 and 12 months
  5. 5.procedural success

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P50-P75 for not_applicable coronary-artery-disease

Timeline
Completed

Started Oct 2011

Longer than P75 for not_applicable coronary-artery-disease

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 12, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 13, 2011

Completed
9 months until next milestone

Study Start

First participant enrolled

October 1, 2011

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

August 20, 2014

Status Verified

August 1, 2014

Enrollment Period

5.5 years

First QC Date

January 12, 2011

Last Update Submit

August 19, 2014

Conditions

Keywords

Magnetic navigation, percutaneous coronary intervention

Outcome Measures

Primary Outcomes (1)

  • Total procedural contrast fluid use

    1 year

Secondary Outcomes (5)

  • Short-term procedural success

    1 year

  • Procedure Fluoroscopy

    1 year

  • Procedure time

    1 year

  • Short term contrast nephropathy

    1 year

  • MACCE at 1 month and 12 months

    2 years

Study Arms (2)

Magnetic navigation PCI

EXPERIMENTAL

These patients will be treated with magnetically navigated percutaneous coronary intervention

Procedure: Magnetic navigation PCI

Conventional PCI

ACTIVE COMPARATOR

These patients will be treated with normal standard percutaneous coronary intervention

Procedure: Conventional PCI

Interventions

Magnetically navigated angioplasty wire technique

Also known as: coronary angioplasty, Percutaneous coronary intervention
Magnetic navigation PCI

Conventional manual angioplasty wire percutaneous coronary intervention

Also known as: coronary angioplasty, Percutaneous coronary intervention
Conventional PCI

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age\>18 years
  • Elective presentation for PCI, This implies that the coronary anatomy is known and can be analysed according to the clinical prediction rule.(13)
  • The included patients must have a calculated formula with a result equal or greater than 6.
  • Pct=1\*Vb+1\*(Vl=1)+2\*(Vl=2)+2\*Vc+1\*Lbb)+1\*(Ll=1)+2\*(Ll=2)
  • Pct - Predicted crossing time (prolonged if integer ≥ 6). Vb - Number of bends before the lesion. Each bend causes deformation of the wire resulting in friction. A greater number of bends leads to increased friction resulting in more difficultly in manipulating the wire.
  • Vl - End-to-end length from the ostium to the lesion. The more distal the lesion is from the ostium, then the greater the chance of encountering problematic bends that impair manipulation, and also the longer the time required to physically pass the wire. This is divided into shorter than 50 mm (=0), between 50 and 100 mm (=1) and greater then 100 mm (=2).
  • Vc - Vessel calcification. Calcium may increase friction as the vessel becomes more rigid and less deformable and does not conform to the wire. The frictive effect of a specific angle will be accentuated if deformation cannot occur.
  • Lbb - Side-branches within 10 mm. Side-branches within 10 mm of the lesion increase difficultly because, on the approach to a lesion finer control is necessary, the fixed wire-tip angle needed for bends now may have more of a predisposition for side-branches.
  • Ll - Lesion length. Longer lesions produce more friction on the wire. The detailed analysis of 3D reconstruction by the Paeion system has been described earlier.(12) This rule was tested on a validation group taken from a second cohort of 415 lesions. The c-statistic derived from this group was 0.82 showing good discrimination.
  • Patients can be admitted from the lounge, the ward or the CCU
  • Diagnostic coronary angiography films suitable for 3D reconstruction Informed consent obtained.

You may not qualify if:

  • Active bleeding
  • Cardiogenic shock
  • Resuscitation / intubation
  • Cerebrovascular accident within 30 days
  • Major bleeding within 30 days according to the TIMI definitions
  • Severe hypertension (\>180/110) after medical treatment
  • Relevant trauma or surgery within 6 weeks
  • Active peptic ulcer within 3 months
  • Hemorrhagic retinopathy
  • Thrombocytopenia (\<150)
  • Severe renal dysfunction (Creatinine \>140)
  • Ongoing or desired use of GpIIb/IIIa blockers
  • Participation in another clinical study
  • Women who are pregnant or women who are breast-feeding. Inability to follow the patient (e.g. foreign or long-distance patients on holiday)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Onze Lieve Vrouwe Gasthuis

Amsterdam, North Holland, 1091 AC, Netherlands

RECRUITING

MeSH Terms

Conditions

Coronary Artery Disease

Interventions

Angioplasty, BalloonPercutaneous Coronary Intervention

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

AngioplastyCatheterizationTherapeuticsEndovascular ProceduresVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical ProceduresInvestigative Techniques

Study Officials

  • Mark S Patterson, PhD

    Onze Lieve Vrouwe Gasthuis

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mark S Patterson, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD PhD

Study Record Dates

First Submitted

January 12, 2011

First Posted

January 13, 2011

Study Start

October 1, 2011

Primary Completion

April 1, 2017

Study Completion

April 1, 2018

Last Updated

August 20, 2014

Record last verified: 2014-08

Locations